(Q65391514)
Statements
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (English)
0 references
October 2005
0 references
February 2007
0 references
157
0 references
18 year
0 references
80 year
0 references